XML 17 R4.htm IDEA: XBRL DOCUMENT v3.23.2
Consolidated Condensed Statements of Operations and Comprehensive (Loss) (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Revenues $ 45,112 $ 65,901 $ 47,263 $ 117,950
Cost of goods sold 43,156 66,115 46,602 121,249
Gross profit (loss) 1,956 (214) 661 (3,299)
Research and development expenses 37 51 79 87
Selling, general and administrative expenses 9,709 7,421 20,495 14,727
Operating loss (7,790) (7,686) (19,913) (18,113)
Interest expense        
Interest rate expense 8,299 4,928 15,377 9,363
Debt related fees and amortization expense 1,330 1,740 3,299 3,566
Accretion and other expenses of Series A preferred units 6,885 1,506 12,449 3,146
Gain on litigation 0 (1,400) 0 (1,400)
Other income (91) (14,254) (167) (14,295)
Loss before income taxes (24,213) (206) (50,871) (18,493)
Income tax expense 1,066 3 818 10
Net loss (25,279) (209) (51,689) (18,503)
Other comprehensive loss        
Foreign currency translation gain (loss) 16 (390) 133 (584)
Comprehensive loss $ (25,263) $ (599) $ (51,556) $ (19,087)
Net loss per common share        
Basic (in dollars per share) $ (0.68) $ (0.01) $ (1.40) $ (0.54)
Diluted (in dollars per share) $ (0.68) $ (0.01) $ (1.40) $ (0.54)
Weighted average shares outstanding        
Basic (in shares) 37,179 34,536 36,804 34,128
Diluted (in shares) 37,179 34,536 36,804 34,128